Silo Pharma Inc

Receive alerts
Market Cap:
$28.11 m
0.33 USD
52 weeks high
52 weeks low

In brief

Silo Pharma Inc. is a developmental stage biopharmaceutical company focused on merging traditional therapeutics with psychedelic research. Silo Pharma Inc’s mission is to identify assets to license and fund the research which we believe will be transformative to the well-being of patients and the health care industry. In these uncertain times, the mental health of the nation and beyond is being put to the test. More than ever, creative new therapies and lines of thought are needed to address health challenges of today. Combining our resources with world-class medical research partners, the company looks to make significant advances in the medical and psychedelic space.

Insight Widest with the analysis, Proactive gives perspectives that others don't.

Three companies pushing the field of psychedelic medicine forward to present at Proactive virtual conference on February 23

Hear executives from Silo Pharma and Lobe Sciences at Proactive's psychedelic-themed virtual showcase event on Tuesday, February 23

3 days, 2 hours ago